FDA Inspection 854699 — Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hubei Gedian Humanwell Pharmaceutical Co., Ltd. on October 17, 2013 in Ezhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- October 17, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ezhou (China)